| 1 | positive regulation of respiratory burst (GO:0060267) | 8.67957699 |
| 2 | angiotensin maturation (GO:0002003) | 8.26682684 |
| 3 | disruption of cells of other organism (GO:0044364) | 8.11710003 |
| 4 | killing of cells of other organism (GO:0031640) | 8.11710003 |
| 5 | defense response to fungus (GO:0050832) | 8.05588304 |
| 6 | antibacterial humoral response (GO:0019731) | 7.53195157 |
| 7 | antimicrobial humoral response (GO:0019730) | 7.32529589 |
| 8 | glomerular filtration (GO:0003094) | 7.13035550 |
| 9 | renal filtration (GO:0097205) | 6.49431375 |
| 10 | regulation of bile acid biosynthetic process (GO:0070857) | 6.49076477 |
| 11 | regulation of guanylate cyclase activity (GO:0031282) | 6.15510033 |
| 12 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.81450625 |
| 13 | vitamin A metabolic process (GO:0006776) | 5.79083042 |
| 14 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.74971305 |
| 15 | regulation of respiratory burst (GO:0060263) | 5.73318563 |
| 16 | digestive system process (GO:0022600) | 5.59278791 |
| 17 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 5.58215752 |
| 18 | actin filament depolymerization (GO:0030042) | 5.57785384 |
| 19 | intestinal epithelial cell development (GO:0060576) | 5.44556641 |
| 20 | flavonoid metabolic process (GO:0009812) | 5.38990071 |
| 21 | positive regulation of pseudopodium assembly (GO:0031274) | 5.30131499 |
| 22 | adhesion of symbiont to host cell (GO:0044650) | 4.92705040 |
| 23 | virion attachment to host cell (GO:0019062) | 4.92705040 |
| 24 | endocrine process (GO:0050886) | 4.91353386 |
| 25 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.91353386 |
| 26 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.91353386 |
| 27 | innate immune response in mucosa (GO:0002227) | 4.87975892 |
| 28 | oligosaccharide biosynthetic process (GO:0009312) | 4.86258932 |
| 29 | glucose 6-phosphate metabolic process (GO:0051156) | 4.78365486 |
| 30 | regulation of pseudopodium assembly (GO:0031272) | 4.75729559 |
| 31 | drug catabolic process (GO:0042737) | 4.66201184 |
| 32 | transepithelial transport (GO:0070633) | 4.59241656 |
| 33 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.51609676 |
| 34 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 4.46307470 |
| 35 | response to fungus (GO:0009620) | 4.41953928 |
| 36 | regulation of vitamin metabolic process (GO:0030656) | 4.31534853 |
| 37 | regulation of systemic arterial blood pressure (GO:0003073) | 4.29682633 |
| 38 | renal system process involved in regulation of blood volume (GO:0001977) | 4.22291189 |
| 39 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.18584325 |
| 40 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.18584325 |
| 41 | urea cycle (GO:0000050) | 4.17573546 |
| 42 | urea metabolic process (GO:0019627) | 4.17573546 |
| 43 | lipoprotein metabolic process (GO:0042157) | 4.15553221 |
| 44 | NADH metabolic process (GO:0006734) | 4.13610378 |
| 45 | mucosal immune response (GO:0002385) | 4.08324420 |
| 46 | sperm capacitation (GO:0048240) | 4.07339051 |
| 47 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 4.05788465 |
| 48 | response to hepatocyte growth factor (GO:0035728) | 4.05788465 |
| 49 | bicarbonate transport (GO:0015701) | 4.05055415 |
| 50 | plasma lipoprotein particle assembly (GO:0034377) | 4.02175427 |
| 51 | cellular glucuronidation (GO:0052695) | 3.98023880 |
| 52 | regulation of cholesterol homeostasis (GO:2000188) | 3.94435209 |
| 53 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.94217224 |
| 54 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.94165628 |
| 55 | protein-lipid complex assembly (GO:0065005) | 3.93567614 |
| 56 | adhesion of symbiont to host (GO:0044406) | 3.93396945 |
| 57 | membrane repolarization during action potential (GO:0086011) | 3.92705329 |
| 58 | complement activation, classical pathway (GO:0006958) | 3.89616468 |
| 59 | glucuronate metabolic process (GO:0019585) | 3.89335570 |
| 60 | uronic acid metabolic process (GO:0006063) | 3.89335570 |
| 61 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.87578080 |
| 62 | digestion (GO:0007586) | 3.86525521 |
| 63 | regulation of cGMP biosynthetic process (GO:0030826) | 3.86388740 |
| 64 | organ or tissue specific immune response (GO:0002251) | 3.84585259 |
| 65 | regulation of triglyceride catabolic process (GO:0010896) | 3.82119274 |
| 66 | modified amino acid transport (GO:0072337) | 3.80355082 |
| 67 | phospholipid efflux (GO:0033700) | 3.76534384 |
| 68 | regulation of cholesterol esterification (GO:0010872) | 3.75141707 |
| 69 | hormone catabolic process (GO:0042447) | 3.73785674 |
| 70 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.72712322 |
| 71 | ethanol oxidation (GO:0006069) | 3.72142927 |
| 72 | bile acid and bile salt transport (GO:0015721) | 3.70985402 |
| 73 | nitrogen cycle metabolic process (GO:0071941) | 3.68365002 |
| 74 | cholesterol homeostasis (GO:0042632) | 3.68339876 |
| 75 | epoxygenase P450 pathway (GO:0019373) | 3.66101883 |
| 76 | cell killing (GO:0001906) | 3.65705874 |
| 77 | ethanol metabolic process (GO:0006067) | 3.65607896 |
| 78 | regulation of cellular extravasation (GO:0002691) | 3.65392885 |
| 79 | sterol homeostasis (GO:0055092) | 3.64701771 |
| 80 | cGMP-mediated signaling (GO:0019934) | 3.60301769 |
| 81 | cGMP biosynthetic process (GO:0006182) | 3.60129526 |
| 82 | diacylglycerol metabolic process (GO:0046339) | 3.59004313 |
| 83 | transcytosis (GO:0045056) | 3.56791082 |
| 84 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.55422986 |
| 85 | primary alcohol catabolic process (GO:0034310) | 3.53341533 |
| 86 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.48284138 |
| 87 | lipoprotein transport (GO:0042953) | 3.48198380 |
| 88 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.48071175 |
| 89 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.48071175 |
| 90 | eosinophil chemotaxis (GO:0048245) | 3.46907240 |
| 91 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.45460312 |
| 92 | cholesterol transport (GO:0030301) | 3.43871163 |
| 93 | sterol transport (GO:0015918) | 3.43871163 |
| 94 | sulfate transmembrane transport (GO:1902358) | 3.42947996 |
| 95 | cholesterol efflux (GO:0033344) | 3.41846258 |
| 96 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.39737213 |
| 97 | homocysteine metabolic process (GO:0050667) | 3.37451582 |
| 98 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.33883209 |
| 99 | peptide catabolic process (GO:0043171) | 3.33328538 |
| 100 | sulfate transport (GO:0008272) | 3.33191724 |
| 101 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.33036229 |
| 102 | O-glycan processing (GO:0016266) | 3.30770733 |
| 103 | peptide hormone processing (GO:0016486) | 3.26131342 |
| 104 | filopodium assembly (GO:0046847) | 3.24944162 |
| 105 | striated muscle atrophy (GO:0014891) | 3.23133269 |
| 106 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.22724808 |
| 107 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.22108659 |
| 108 | epithelial structure maintenance (GO:0010669) | 3.22001532 |
| 109 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.18590181 |
| 110 | glucocorticoid biosynthetic process (GO:0006704) | 3.16792909 |
| 111 | desmosome organization (GO:0002934) | 3.16727273 |
| 112 | drinking behavior (GO:0042756) | 3.15460052 |
| 113 | regulation of cGMP metabolic process (GO:0030823) | 3.14411564 |
| 114 | fructose metabolic process (GO:0006000) | 3.14267032 |
| 115 | negative regulation of cholesterol transport (GO:0032375) | 3.13633662 |
| 116 | negative regulation of sterol transport (GO:0032372) | 3.13633662 |
| 117 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.12293126 |
| 118 | glycosphingolipid catabolic process (GO:0046479) | 3.12192290 |
| 119 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.11384113 |
| 120 | alkaloid metabolic process (GO:0009820) | 3.09931942 |
| 121 | proline biosynthetic process (GO:0006561) | 3.08924492 |
| 122 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.08073447 |
| 123 | eosinophil migration (GO:0072677) | 3.07881104 |
| 124 | sulfation (GO:0051923) | 3.07312481 |
| 125 | complement activation (GO:0006956) | 3.06204247 |
| 126 | sulfur compound transport (GO:0072348) | 3.05539791 |
| 127 | endocrine pancreas development (GO:0031018) | 3.05414245 |
| 128 | negative regulation of myotube differentiation (GO:0010832) | 3.04965814 |
| 129 | regulation of digestive system process (GO:0044058) | 3.03679911 |
| 130 | phospholipid scrambling (GO:0017121) | 3.03555098 |
| 131 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.03343084 |
| 132 | glycolipid catabolic process (GO:0019377) | 3.03054096 |
| 133 | arginine metabolic process (GO:0006525) | 3.02815328 |
| 134 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.01276683 |
| 135 | GDP-mannose metabolic process (GO:0019673) | 3.00656535 |
| 136 | tight junction assembly (GO:0070830) | 3.00020077 |
| 137 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.99642683 |
| 138 | regulation of actin nucleation (GO:0051125) | 2.99441639 |
| 139 | protein targeting to Golgi (GO:0000042) | 2.98868547 |
| 140 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.95666689 |
| 141 | thyroid hormone metabolic process (GO:0042403) | 2.95621106 |
| 142 | negative regulation of steroid metabolic process (GO:0045939) | 2.93709375 |
| 143 | positive regulation of establishment of protein localization to plasma membrane (GO:0090004) | 2.93511982 |
| 144 | cellular response to pH (GO:0071467) | 2.89118606 |
| 145 | labyrinthine layer development (GO:0060711) | 2.86590619 |
| 146 | glycosylceramide metabolic process (GO:0006677) | 2.86544124 |
| 147 | sodium ion homeostasis (GO:0055078) | 2.83479065 |
| 148 | auditory receptor cell differentiation (GO:0042491) | 2.76356570 |
| 149 | sexual reproduction (GO:0019953) | 2.75885518 |
| 150 | positive regulation of cGMP biosynthetic process (GO:0030828) | 2.73498450 |
| 151 | receptor recycling (GO:0001881) | 2.71902705 |
| 152 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.69987160 |
| 153 | arginine catabolic process (GO:0006527) | 2.64969591 |
| 154 | thrombin receptor signaling pathway (GO:0070493) | 2.64404633 |
| 155 | drug metabolic process (GO:0017144) | 2.63745307 |
| 156 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.63292381 |
| 157 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.61720289 |
| 158 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.57277429 |
| 159 | intestinal absorption (GO:0050892) | 12.0078215 |
| 160 | intestinal cholesterol absorption (GO:0030299) | 10.2385966 |
ITLN1 
